2016 was a big year for PGx Medical with growth, new partnerships and a new website
Clay Bullard, President, PGx Medical
We want to start by saying “thank you” to our partners, clients and employees. We are truly blessed to have such a wonderful team!
We kicked off January 2016 by adding bipolar and seizure to our list of medication classes giving healthcare professionals more information then ever before. With this addition, our program now offers the most comprehensive PGx test report on the market.
We have been in our new building for two years and have expanded our team. With the addition of a full time Client Service Coordinator and a Clinical Sales and Support Coordinator, PGx Medical continues to grow and expand as the market demands.
Throughout the year, I was privileged to speak to many senior communities, conferences and healthcare organizations about our program and how pharmacogenetic testing addresses key clinical concerns such as falls, dementia, pain, sleep and staff efficiencies.
In August, PGx Medical expanded our focus into the field of aging services. With the launch of a new website, a pilot program and partnership with Dr. Linda Shell, we were able to reach more healthcare professionals than ever before.
We also had the privilege to partner with physicians and pharmacists who understand the value of the program and use pharmacogenetics in their day-to-day patient care. These partners have been instrumental in educating others through online video, articles, local media outlets and case studies on outcomes based on changes from test results. We are appreciative and humbled by their willingness to share these stories.
During 2016, we partnered with one of the largest Oklahoma state agencies to manage their PGx Feasibility Pilot Program. Results and benefits analysis for the pilot will be available in Q1 of 2017. This is one of the largest pilot programs of its kind and we were honored to be able to partner with the State of Oklahoma.
Pharmacogenetic testing has received a lot of attention over the years under the umbrella of Precision Medicine, and we are excited to see that continue. Future outlook is good and precision medicine will continue to grow and expand as new CMS regulatory requirements rollout 2017-2018 for unnecessary drugs.
We look forward to long-lasting relationships with current clients and new partnerships in the coming year.
Enjoy the holidays! As always, you can contact us anytime with questions, comments or to schedule an appointment or speaking engagement.
PGx Medical
Individualized Care – Personalized Medicine
www.pgxmed.com
405-509-5112
info@pgxmed.com